Beam Therapeutics BEAM Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Beam Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's operating margin?
- Beam Therapeutics (BEAM) reported operating margin of -226.6% in Q1 2026.
- How has Beam Therapeutics's operating margin changed year-over-year?
- Beam Therapeutics's operating margin increased by 66.6% year-over-year, from -677.5% to -226.6%.
- What is the long-term trend for Beam Therapeutics's operating margin?
- Over 4 years (2020 to 2025), Beam Therapeutics's operating margin has grown at a -85.1% compound annual growth rate (CAGR), from -553,166.7% to -274.6%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.